Kathryn J. Collier - 25 Jul 2024 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Role
Director
Signature
Christopher Aker, Attorney in Fact
Issuer symbol
RGLS
Transactions as of
25 Jul 2024
Net transactions value
+$7,280
Form type
4
Filing time
29 Jul 2024, 16:18:02 UTC
Previous filing
21 May 2024
Next filing
30 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGLS Common Stock Purchase $7,280 +4,000 +146% $1.82 6,740 25 Jul 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.